122 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

S2P

Simcere Pharmaceutical Group
HK$0.61-0.8%-44.6%HK$13.3bHK$1.03PE17.2xE24.4%3.4%

4RY

Akeso
HK$5.00-12.3%7.8%HK$38.0bHK$6.81PE17.3xE12.2%n/a

GEKA

Genomma Lab Internacional. de
Mex$0.77-9.9%6.2%Mex$14.0bMex$1.08PE13.6xE27.1%5.2%

GIS

Gilead Sciences
US$62.32-2.3%-20.8%US$83.2bUS$79.58PE14.7xE10.0%4.6%

RIG2

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Ft22.50-6.2%10.3%Ft1.6tFt29.66PE10.2xE17.0%4.8%

87S

Roivant Sciences
US$9.31-7.4%20.9%US$8.4bUS$14.31PE1.9xE-54.3%n/a

GIS

Gilead Sciences
US$62.04-3.2%-21.1%US$83.2bUS$79.22PE14.7xE10.0%4.6%

29A

Amphastar Pharmaceuticals
US$35.50-4.2%-8.0%US$2.0bUS$55.54PE14.2xE19.7%n/a

ICY

Incyte
US$49.49-3.3%-26.3%US$11.8bUS$71.54PE19.7xE20.1%n/a

JNJ0

Johnson & Johnson
US$13.10-2.2%n/aUS$356.4bUS$15.28PE18.6xE5.1%3.2%

17Q1

Pharmaron Beijing
CN¥0.91-11.7%-64.3%CN¥29.4bCN¥1.29PE20.3xE12.3%1.1%

LDZA

Aspen Pharmacare Holdings
R10.50-1.9%16.7%R96.6bR11.02PE19.8xE25.1%1.6%

RPD

Royalty Pharma
US$25.78-2.6%-21.4%US$16.8bUS$41.56PE11.1xE6.0%3.0%

LDZU

Aspen Pharmacare Holdings
R10.20-1.9%16.6%R96.6bR10.70PE19.8xE25.1%1.6%

MX6A

Grand Pharmaceutical Group
HK$0.47-3.3%-14.9%HK$13.9bn/aPE7.4xE20.0%6.5%

BRM

Bristol-Myers Squibb
US$45.46-0.7%-29.0%US$99.2bUS$52.33PE12.4xE8.3%4.9%

RGO

Regeneron Pharmaceuticals
US$836.00-1.8%15.6%US$96.4bUS$965.44PE24.4xE10.9%n/a

GS70

GSK
UK£37.00-2.6%10.8%UK£65.3bUK£46.41PE13.3xE9.4%3.6%

GS71

GSK
UK£18.45-3.9%11.3%UK£65.3bUK£23.14PE13.3xE9.4%3.6%

5HZ1

Hangzhou Tigermed Consulting
CN¥3.48-8.9%-58.3%CN¥40.1bCN¥4.42PE21.2xE13.6%1.1%

R2WA

Beximco Pharmaceuticals
৳0.457.1%-9.6%৳52.5bn/aPE10.7xE15.0%3.0%

C1S

China Shineway Pharmaceutical Group
HK$1.09-5.2%11.8%HK$7.1bHK$1.63PE6.8xE14.5%6.1%

P731

Medexus Pharmaceuticals
CA$1.030%8.4%CA$40.4mCA$2.00PE5xE46.9%n/a

VV5

Vext Science
CA$0.16-12.4%-12.4%CA$58.9mn/aPE8.5xS31.3%n/a
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.